Baroda BNP Paribas Health and Wellness Fund holds 35 instruments (97.06% equity), led by Sun Pharmaceutical Industries Limited (8.58%), Torrent Pharmaceuticals Limited (7.88%) and Divi's Laboratories Limited (7.82%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Baroda BNP Paribas Health and Wellness Fund, managed by Baroda BNP Paribas Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 35 instruments with an equity allocation of 97.06%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Baroda BNP Paribas Health and Wellness Fund's top 10 holdings account for 58.36% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 93.48% of net assets, spread across 3 sectors in total. Since its 31 August 2026 disclosure, the fund added 1 new position and exited 1 position, with AstraZeneca Pharma India Limited seeing the largest move (-0.77pp to 2.79%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Laurus Labs Limited | 5.66% → 6.09% | ▲ +0.43 |
| SYMBIOTEC PHARMALAB LTD | 1.18% → 1.47% | ▲ +0.29 |
| Mankind Pharma Limited | 3.1% → 3.34% | ▲ +0.24 |
| Dr. Lal Path Labs Ltd. | 3.24% → 3.47% | ▲ +0.23 |
| Abbott India Limited | 2.29% → 2.5% | ▲ +0.21 |
| Acutaas Chemicals Limited | 2.24% → 2.36% | ▲ +0.12 |
| Dr. Reddy's Laboratories Limited | 1.14% → 1.26% | ▲ +0.12 |
| Stock | Weight | Change |
|---|---|---|
| AstraZeneca Pharma India Limited | 3.56% → 2.79% | ▼ -0.77 |
| Fortis Healthcare Limited | 4.5% → 3.98% | ▼ -0.52 |
| Sun Pharmaceutical Industries Limited | 9.01% → 8.58% | ▼ -0.43 |
| Procter & Gamble Health Limited | 0.57% → 0.17% | ▼ -0.4 |
| Glenmark Pharmaceuticals Limited | 3.42% → 3.11% | ▼ -0.31 |
| Max Financial Services Limited | 2.43% → 2.21% | ▼ -0.22 |
| Lupin Limited | 5.99% → 5.79% | ▼ -0.2 |
| Divi's Laboratories Limited | 8.01% → 7.82% | ▼ -0.19 |
| Metropolis Healthcare Limited | 1.49% → 1.33% | ▼ -0.16 |
| Apollo Hospitals Enterprise Limited | 5.44% → 5.28% | ▼ -0.16 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Baroda BNP Paribas Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.